Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)

CUSIP: 15673T100

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
+16,968,689
Put/Call ratio
4.3%
SEC-reported price per share
$2.55
Number of holders
59
Value change
+$40,961,743
Number of buys
37
Open additional details 1 more signal available
Number of sells
26
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
180,747,818

Security key

15673T100

Report period

Q2 2024

Institutions

59

Top holders

10

Ownership snapshot

Top reported holders of IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAYER AKTIENGESELLSCHAFT
Disclosed value leader
BAYER AKTIENGESELLSCHAFT
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5 13F Highest disclosed value: $18,886,999 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BAYER AKTIENGESELLSCHAFT has the largest disclosed position value at $18.89M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAYER AKTIENGESELLSCHAFT's linked filing trail.
Disclosed position value Top 5
BAYER AKTIENGESELLSCHAFT $18.89M
Versant Venture Capital VI, L.P. $18.13M
FUJIFILM Cellular Dynamics, Inc. $10.36M
Venrock Adviser, LLC $14.23M
FMR LLC $14.09M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAYER AKTIENGESELLSCHAFT
3/4/5
10%+ Owner
—
denominator unverified
$18,886,999
12,675,838 shares
— 22 Jun 2021
Versant Venture Capital VI, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$18,127,503
12,166,109 shares
— 09 Aug 2022
FUJIFILM Cellular Dynamics, Inc.
3/4/5
10%+ Owner
—
denominator unverified
$10,363,258
6,955,207 shares
— 22 Jun 2021
Venrock Adviser, LLC
13F
Company
13F
—
denominator unverified
$14,233,456
3,405,133 shares
— 31 Mar 2024
FMR LLC
13F
Company
13F
—
denominator unverified
$14,091,732
3,371,228 shares
— 31 Mar 2024
Casdin Capital, LLC
13F
Company
13F
—
denominator unverified
$13,402,668
3,206,380 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
59
Shares
40,117,934
Rows available
59
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q4 2025 Across Filers

Q4 2025 holders
46
Q2 2024 holders
59
Holder diff
13
Investor Q4 2025 Shares Q2 2024 Shares Share Diff Share Chg % Q4 2025 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .